- Target
- p16
- Reactivity
- Human,
- Application
- IHC,WB,IF,ELISA
- MW(Calculated)
- 16kD
- MW(Observed)
- 16kD
- Host Species
- Mouse
- Isotype
- IgG2b,Kappa
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- IHC 1:200-1000;WB 1:500-2000;IF 1:100-500;ELISA 1:1000-5000
- Form
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source
- --
- Purification
- Protein G
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- --
- Clonality
- Monoclonal
- Clone No.
- PTR2301
- Immunogen
- Synthesized peptide derived from human p16 INK AA range: 100-156
- Sequence
- --
- Specificity
- This antibody detects endogenous levels of p16 INK protein.
- Gene Name
- CDKN2A CDKN2 MTS1
- Protein Name
- Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3
- Other Name
- CDKN2A;CDKN2;MTS1;Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3;Cyclin-dependent kinase 4 inhibitor A;CDK4I;Multiple tumor suppressor 1;MTS-1;p16-INK4a;p16-INK4;p16INK4A;p16;
- Organism-1
- Human
- Gene ID-1
- 1029
- SwissProt-1
- P42771
- Organism-2
- --
- Gene ID-2
- --
- SwissProt-2
- --
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Nuclear